Treatment Result of Proton Pump Inhibitor, Steroid Inhaler and Botulinum Tonxin Injection for Contact Granuloma

양성자펌프억제제, 스테로이드흡입제, 보툴리늄톡신 주사를 이용한 접촉성 육아종의 치료 결과

  • Park, Hyoung Min (Department of Otorhinolaryngology Head and Neck Surgery, School of Medicine, Gachon University, Gil Medical Center) ;
  • Oh, Na Rae (Department of Otorhinolaryngology Head and Neck Surgery, School of Medicine, Gachon University, Gil Medical Center) ;
  • Baek, Min Kwan (Department of Otorhinolaryngology Head and Neck Surgery, School of Medicine, Gachon University, Gil Medical Center) ;
  • Kim, Dong Young (Department of Otorhinolaryngology Head and Neck Surgery, School of Medicine, Gachon University, Gil Medical Center) ;
  • Woo, Joo Hyun (Department of Otorhinolaryngology Head and Neck Surgery, School of Medicine, Gachon University, Gil Medical Center)
  • 박형민 (가천대학교 의과대학 이비인후과학교실) ;
  • 오나래 (가천대학교 의과대학 이비인후과학교실) ;
  • 백민관 (가천대학교 의과대학 이비인후과학교실) ;
  • 김동영 (가천대학교 의과대학 이비인후과학교실) ;
  • 우주현 (가천대학교 의과대학 이비인후과학교실)
  • Received : 2017.03.29
  • Accepted : 2017.06.02
  • Published : 2017.06.30

Abstract

Background and Objectives : This study evaluated the efficacy of combination therapy of proton pump inhibitor (PPI) and steroid inhaler (SI), with or without botulinum toxin injection (BTX) for contact granuloma. Subjects and Methods : Fourteen contact granuloma patients were enrolled in this study. Combination therapy of PPI and SI were used for the first line treatment. When combination therapy was not effective, BTX was performed as the second method. Treatment results were recorded as responsible or non-responsible. Farwell grade, size, history of voice abuse, gender, and reflux finding score (RFS) were compared between responsible group and non-responsible group. Results : Initial response rate was 28.6% after treatment of PPI and SI. BTX was performed on three un-responsible patients. After BTX injection, three patients had complete remission of granuloma. Final response rate was 50.0%. Un-responsible group had significantly higher RFS than responsible group. Conclusion : The efficacy of PPI and SI was limited for contact granuloma in this study. Botulium toxin injection was recommended in early phase when PPI and SI did not effective for contact granuloma. Prospective studies evaluating the effects of PPI and SI are warranted.

Keywords

References

  1. Ylitalo R, Linestad PA. Laryngeal findings in patients with contact granuloma: a long-term follow-up study. Acta Otolaryngol 2000;120: 655-9. https://doi.org/10.1080/000164800750000504
  2. Emami AJ, Morrison M, Rammage L, Bosch D. Treatment of laryngeal contact ulcers and granulomas: a 12-year retrospective analysis. J Voice 1999;13:612-7. https://doi.org/10.1016/S0892-1997(99)80015-0
  3. Carroll TL, Gartner-Schmidt J, Statham MM, Rosen CA. Vocal process granuloma and glottal insufficiency: an overlooked etiology? Laryngoscope 2010;120:114-20. https://doi.org/10.1002/lary.21321
  4. Orloff LA, Goldman SN. Vocal fold granuloma: successful treatment with botulinum toxin. Otolaryngol Head Neck Surg 1999;121: 410-3. https://doi.org/10.1016/S0194-5998(99)70230-5
  5. Roh HJ, Goh EK, Chon KM, Wang SG. Topical inhalant steroid (budesonide, Pulmicort nasal) therapy in intubation granuloma. J Laryngol Otol 1999;113:427-32. https://doi.org/10.1017/S0022215100144147
  6. Clyne SB, Halum SL, Koufman JA, Postma GN. Pulsed dye laser treatment of laryngeal granulomas. Ann Otol Rhinol Laryngol 2005; 114:198-201. https://doi.org/10.1177/000348940511400305
  7. Mitchell G, Pearson CR, Henk JM, Rhys-Evans P. Excision and low-dose radiotherapy for refractory laryngeal granuloma. J Laryngol Otol 1998;112:491-3. https://doi.org/10.1017/S0022215100140873
  8. Lee SW, Hong HJ, Choi SH, Sun DI, Park YH, Lee BJ, et al. Comparison of treatment modalities for contact granuloma: a nationwide multicenter study. Laryngoscope 2014;124:1187-91. https://doi.org/10.1002/lary.24470
  9. Lee JC, Wang SG. Management of vocal process granuloma. Korean J Otolaryngol 2005;48:70-3.
  10. Havas TE, Priestley J, Lowinger DS. A management strategy for vocal process granulomas. Laryngoscope 1999;109:301-6. https://doi.org/10.1097/00005537-199902000-00023
  11. Wani MK, Woodson GE. Laryngeal contact granuloma. Laryngoscope 1999;109:1589-93. https://doi.org/10.1097/00005537-199910000-00008
  12. Hillel AT, Lin LM, Samlan R, Starmer H, Leahy K, Flint PW. Inhaled triamcinolone with proton pump inhibitor for treatment of vocal process granulomas: a series of 67 granulomas. Ann Otol Rhinol Laryngol 2010;119(5):325-30. https://doi.org/10.1177/000348941011900509
  13. Nasri S, Sercarz JA, McAlpin T, Berke GS. Treatment of vocal fold granuloma using botulinum toxin type A. Laryngoscope 1995;105(6):585-8. https://doi.org/10.1288/00005537-199506000-00005
  14. Damrose EJ, Damrose JF. Botulinum toxin as adjunctive therapy in refractory laryngeal granuloma. J Laryngol Otol 2008;122(8):824-8. https://doi.org/10.1017/S0022215107000710
  15. Yilmaz, T, Kayahan B, Gunaydin RO, Kuscu O, Sozen T. Botulium toxin A for treatment of contact granuloma. J Voice 2016;30(6):741-3. https://doi.org/10.1016/j.jvoice.2015.07.015
  16. Yilmaz T, Suslu N, Atay G, Ozer S, Gunaydin RO, Bajin MD. Recurrent contact granuloma. JAMA Otolaryngology Head Neck Surg 2013;139(6):579-83. https://doi.org/10.1001/jamaoto.2013.3186